BioCryst Pharmaceuticals
Tracked across 1 events · 6 articles · First seen Jul 15, 2026 · Last active Jul 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: BioCryst appointed David Jenkins as CSO to lead external innovation efforts, reinforcing its strategic pivot toward partnerships for rare disease therapies.
Jul 15, 2026 · 6 articles
ERGEN INTELLIGENCE
Track BioCryst Pharmaceuticals live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard